Available Technologies

Browse Penn-owned technologies available for licensing.

HOME SEARCH RSS FEED

Search Results - alba+rodriguez-garcia

1 Results Sort By:

CAR T cell therapy for the treatment of ovarian cancer and other gynecologic malignancies

Anti-Mullerian inhibiting substance type II receptor (MISRII) specific CAR T cell therapy for the targeted, safe treatment of ovarian cancer. Technology Overview: Ovarian cancer is the 5th leading cause of cancer-related deaths in women and is the most lethal of all gynecologic malignancies with an overall 5-year survival rate of 46%. The Müllerian...

Published: 3/11/2020

Inventor(s):

Keywords(s):

 

Category(s):